1. World Health Organization. Pneumococcal vaccines WHO position paper—2012. Wkly Epidemiol Rec. 2012;87:129–44.
2. Sanofi Pasteur MSD. Pneumovax II solution for injection in a vial: summary of product characteristics. 2013. http://www.medicines.org.uk/emc/medicine/1446/SPC/Pneumovax+II/ . Accessed Sept 29, 2014.
3. Pfizer. Prevenar: summary of product characteristics. 2013. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000323/WC500041563.pdf . Accessed Sept 29, 2014.
4. GlaxoSmithKline. Synflorix suspension for injection in pre-filled syringe: summary of product characteristics. 2012. http://www.medicines.org.uk/emc/medicine/22743/SPC/Synflorix+suspension+for+injection+in+pre-filled+syringe/ . Accessed Sept 29, 2014.
5. Pfizer. Prevenar 13 suspension for injection: summary of product characteristics. 2013. http://www.medicines.org.uk/emc/medicine/22689/SPC/Prevenar+13+suspension+for+injection/ . Accessed Sept 29, 2014.